Crossmark Global Holdings, Inc. Zai Lab LTD Transaction History

Crossmark Global Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$27.77 - $64.4 $103,026 - $238,924	-3,710 Closed	0 $0
Q4 2021 Jan 10, 2022	BUY	$54.9 - $105.21 $62,586 - $119,939	1,140 Added 44.36%	3,710 $233,000
Q3 2021 Oct 21, 2021	BUY	$105.0 - $178.37 $269,850 - $458,410	2,570 New	2,570 $271,000
Q3 2021 Oct 13, 2021	SELL	$105.0 - $178.37 $281,400 - $478,031	-2,680 Closed	0 $0
Q2 2021 Jul 21, 2021	BUY	$125.11 - $180.0 $8,757 - $12,600	70 Added 2.68%	2,680 $474,000
Q1 2021 Apr 15, 2021	BUY	$126.27 - $191.71 $329,564 - $500,363	2,610 New	2,610 $348,000

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.95B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.